Stay updated on MiST: Multi-drug Phase II Clinical Trial
Sign up to get notified when there's something new on the MiST: Multi-drug Phase II Clinical Trial page.

Latest updates to the MiST: Multi-drug Phase II Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe additions explain that PubMed publications are auto-filled and add a revision tag (v3.3.2); the deletions describe the PubMed source and include an older revision tag (v3.2.0).SummaryDifference0.1%

- Check23 days agoChange DetectedThe government funding lapse notice banner was removed from the page. It previously warned that information might not be up to date and directed users to cc.nih.gov and opm.gov for operating status.SummaryDifference0.4%

- Check37 days agoChange DetectedNo additions or deletions were detected on the study record page. The content remains focused on the MiST trial’s design, eligibility criteria, outcomes, and collaborators.SummaryDifference0.4%

- Check66 days agoChange DetectedAdded a government funding lapse notice and a version upgrade to v3.2.0; removed the previous v3.1.0 tag. This introduces critical information about availability and processing, while updating the platform version.SummaryDifference3%

- Check73 days agoChange DetectedCore content updated with a terminology rearrangement from 'Malignant mesothelioma' to 'Mesothelioma, malignant' and a version bump to v3.1.0, indicating an overall refresh rather than changes to pricing or availability.SummaryDifference0.2%

- Check87 days agoChange DetectedPage now shows Revision: v3.0.2 (replacing v3.0.1); a minor UI element ('Back to Top') was removed. No other substantive content changes were detected.SummaryDifference0.2%

Stay in the know with updates to MiST: Multi-drug Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MiST: Multi-drug Phase II Clinical Trial page.